This patient's history of JAK2 essential thrombocytosis predisposes her to thrombosis formation, which is a significant cause of morbidity and mortality in this patient population and is reported to occur in 20% of patients [7]. The gene discussed is JAK2; the disease is essential thrombocythemia.